Viewing Study NCT00496704


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2025-12-30 @ 3:49 AM
Study NCT ID: NCT00496704
Status: UNKNOWN
Last Update Posted: 2009-08-21
First Post: 2007-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module